My best wishes to MSB and other companies developing stem cells based new cures. My switching fro MSB to CYP is just an investment decision, based on the notion that there are more and more players Elsewhere I saw this link https://endpts.com/citing-significa...s-stem-cell-pipeline-with-new-collaborations/ requiring quality stem cell product which the the Cymerus™ mesenchymal stem cell technology is likely to deliver economically and on a large scale.
I think in the hurdle of proof has been largely de-risked by the tests done this far.
We are close, page-19
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.015(6.38%) |
Mkt cap ! $45.16M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 28.0¢ | 24.5¢ | $103.8K | 408.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 35587 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 7013 | 2 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |